by adminAdrianRamirez | Mar 27, 2019 | Axim Biotechnologies, Press Releases
SAN DIEGO, March 27, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its portfolio company AXIM® Biotechnologies (“AXIM® Biotech” or “AXIM”) (OTCQB:AXIM), a...
by adminAdrianRamirez | Feb 14, 2019 | Kannaway, Press Releases
SAN DIEGO, Feb. 14, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has...
by adminAdrianRamirez | Jan 17, 2019 | HempMeds, Press Releases
SAN DIEGO, Jan. 16, 2019 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today the release of its newest cannabidiol (CBD) product Real Scientific Hemp Oil™ (RSHO™)...
by adminAdrianRamirez | Feb 28, 2018 | Axim Biotechnologies, Press Releases
SAN DIEGO, Feb. 28, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its major investment company AXIM® Biotechnologies (OTC:AXIM) (“AXIM”) has successfully executed their...
by adminAdrianRamirez | Dec 4, 2017 | Axim Biotechnologies, Media Coverage
A marijuana-focused news outlet recently spotlighted MJNA investment company AXIM® Biotechnologies and its upcoming trial of its cannabinoid-based gum for IBS. Medical Marijuana, Inc. investment company AXIM® Biotechnologies and its cannabinoid-based gum were recently...